AAPM has contracted with NCRP to provide each AAPM Member in good standing access and download privileges of electronically available NCRP reports, commentaries and statements. This report was prepared by the National Council on Radiation Protection and Measurements (NCRP). The Council strives to provide accurate, complete and useful information in its reports. However, neither the NCRP, the members of NCRP, other persons contributing to or assisting in the preparation of this report, nor any person acting on the behalf of any of these parties (a) makes any warranty or representation, express or implied, with respect to the accuracy, completeness or usefulness of the information contained in this report, or that the use of any information, method or process disclosed in this report may not infringe on privately owned rights; or (b) assumes any liability with respect to the use of, or for damages resulting from the use of, any information, method or process disclosed in this report.
 |
Report No. 155 - Management of Radionuclide Therapy Patients (2006)  Price: $110 PDF (AAPM Members FREE) Category: Reports NCRP Report No. 155, Management of Radionuclide Therapy Patients, is intended for use by a wide readership including physicians, medical physicists, health physicists, administrators, nurses, other professional and medical staff, and patients. The approaches originally suggested in NCRP Report No. 37, Precautions in the Management of Patients Who Have Received Therapeutic Amounts of Radionuclides (1970), are incorporated and updated. This Report makes recommendations on explaining risks from therapeutic procedures and obtaining adequate, informed patient consent; dose limits for members of the patient's family; patient confinement in a hospital or skilled-care facility; and patient records including the radionuclide and activity used, the treating physician, and contact information. Section 1 of Report No. 155 is an introduction and includes some brief historical items. This Section discusses the basic principles of both radiopharmaceutical therapy and brachytherapy. Section 2 deals with basic radiation safety principles in a medical facility and includes a description of the radiation safety program, dose limits, staffing and definitions specific to this Report. Section 3 addresses radiopharmaceutical therapy including both clinical and radiation safety aspects. Appendices A and B expand on the patient release criteria outlined in Section 3 and include a spreadsheet program for assisting in determining patient release instructions. Section 4 deals specifically with brachytherapy including techniques, terminology, and a brief discussion of applicable dosimetry. Section 5 includes facility design for both nuclear-medicine and radiation-oncology installations. Section 6 describes changes in patients' status, including medical emergencies and includes guidelines for other situations that may be adapted to readers' facilities. Appendix C presents a discussion of quality-assurance requirements for high dose rate afterloading which is an increasingly useful modality. Appendix D outlines shielding requirements for high dose rate brachytherapy installations. ISBN-13: 978-0-929600-92-5 Scientific Committee: Jean St. Germain, Chairman Edward B. Silberstein Richard J. Vetter Jeffrey F. Williamson Pat D. Zanzonico Jerrold T. Bushberg, Liaison Sarah S. Donaldson, Liaison |
DISCLAIMER